Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 January 2025 | Story Lacea Loader | Photo Supplied
Jurie Blignaut
Jurie Blignaut, top achiever in the 2024 matric exams for quintile four schools in SA and finalist of the UFS 2024 Matriculant of the Year competition.

The University of the Free State (UFS) is proud to announce that the top achiever in the 2024 matric exams for quintile four schools in the country, Jurie Blignaut, will be studying towards an MBChB at the UFS from 2025.

Blignaut, a pupil of the Rustenburg High School, was one of the 14 finalists in the 2024 UFS Matriculant of the Year competition.

“Congratulations to Jurie on this wonderful achievement. We look forward to welcoming him and our cohort of 2025 first-year students to our campuses,” says Prof Anthea Rhoda, acting Vice-Chancellor and Principal of the UFS. 

Boasting 11 distinctions and an average of 96,5%, Blignaut is not only an exceptional academic achiever but also participates in several cultural activities. He was the winner of the Kovsie Alumni Trust’s special award for personal cultural achievement in the final round of the competition. This head boy of his school is an excellent public speaker and musician. 

Blignaut’s highest achievement in public speaking was his national second place in last year’s ATKV public speaking competition in the section for Afrikaans home language. He plays the cello and has performed solo with the Pretoria Symphony Orchestra, was part of the school choir and band, and participated in the Stellenbosch International Chamber Music Festival. 

“On behalf of the university management, I would also like to congratulate Dr Mantlhake Maboya, MEC for Education in the Free State, and her executive team on the Free State being the top-achieving province in South Africa,” says Prof Rhoda. 

Other finalists in the 2024 UFS Matriculant of the Year competition who excelled during the matric exams include Susan Bender from Voortrekker High School – top achiever in the Free State province – and Chris Goosen from Grey College Secondary School, who is also one of the top achievers in the Free State. 

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept